anti-SIGLEC15 treated 2
source_name
enriched CD8+ T cells in percutaneous tumor graft
strain
C57BL/6
Sex
male
cell type
enriched CD8+ T cells in percutaneous tumor graft
genotype
wild type
treatment
intraperitoneal injection of SIGLEC15 antibody
geo_loc_name
missing
collection_date
missing